Navigation
Life Science Cluster für Hamburg und Schleswig-Holstein

News

Your contact person

Manager PR & Communications Jan Phillip Denkers

Filter reset
Indivumed and Aptila join forces in a new proteomics collaboration. (Photo: Indivumed)
Indivumed and Aptila join forces in a new proteomics collaboration. (Photo: Indivumed)

Indivumed announces collaboration utilizing Aptila’s proteomics expertise

Indivumed is pleased to announce a close working relationship with Aptila as of August 2025. Aptila’s software suite, DIA-NN, is a leading solution for data-independent ...

Read more …
Moving forward, the Omics Hub will continue to serve as a key resource for clinicians and clinical network partners in order to drive novel research and ultimately improve personalized oncology and the treatment of patients.
Moving forward, the Omics Hub will continue to serve as a key resource for clinicians and clinical network partners in order to drive novel research and ultimately improve personalized oncology and the treatment of patients. (Image: Screenshot/Discover Oncology)

Indivumed: New Publication in Discover Oncology

Indivumed GmbH announced the fourth research publication enabled by the Indivumed Omics Hub. An interface for members of the Indivumed Global Clinical Network, the Omics ...

Read more …
Senator of Economics Affairs Michael Westhagemann (left) and Ralf Sommer, CEO of the Hamburg Investment and Development Bank (right) hand over the notification of funding to Indivumed CEO Prof. Dr. Hartmut Juhl (Image: ©BVM)

Accelerated drug development and personalised treatments for cancer

Indivumed GmbH is a biotech company with international activities and representative offices in the US, Japan, Italy and Brasil. It cooperates with numerous international research ...

Read more …
Job board